A patient presents at the counter with a vaccination reminder prescription, but their medication history reveals a potential interaction with a recent immunosuppressive treatment. The pharmacist has a few minutes to cross-check this data and provide appropriate advice. It is in this type of situation that health and pharmacy news takes on practical significance, far beyond the headlines.
AI and vaccination advice in neighborhood pharmacies: what changes at the counter
There is a lot of talk about artificial intelligence in the hospital sector, but neighborhood pharmacies are beginning to integrate these tools in a very concrete way: personalized vaccination advice. Several pharmacy management software programs now offer decision support modules that cross-reference the patient’s Pharmaceutical Record with current vaccination recommendations.
Read also : Everything You Need to Know About the Benefits of the Protected Lease for Tenants and Landlords
The typical case is the poly-medicated patient over 65 years old. The tool analyzes their ongoing treatments, documented allergic history, and vaccination schedule to flag a contraindication or suggest spacing of doses. AI does not replace the pharmacist; it structures information in real-time so that they can provide more precise advice than the standardized recommendation.
On the ground, feedback varies on this point. Some pharmacists report a significant time saving, while others emphasize that reliability depends entirely on the updating of the Pharmaceutical Record by all prescribers. An AI tool that works with incomplete data produces alerts that are not very actionable. To keep up with these developments on a daily basis, one can consult https://www.pharmactuelle.fr/, which regularly shares advancements in the pharmacy sector.
Read also : Everything You Need to Know About Capillar and Its Use in Health
Digital traceability of opioid prescriptions: the March 2026 decree in practice
Since March 2026, decree n°2026-187 imposes a generalized digital traceability of opioid prescriptions via the Pharmaceutical Record. The stated goal is to limit medical nomadism and prescription abuse. On paper, this is a clear advancement for public health.
In practice, the implementation in pharmacies remains uneven. The decree assumes that each prescriber properly updates the record, which is not yet systematic. Pharmacists sometimes find themselves dispensing an opioid treatment without complete visibility of the patient’s previous prescriptions at other facilities.
What the pharmacist checks concretely
- The consistency between the prescription and the dispensing history recorded in the Pharmaceutical Record, to identify any potential overlap of prescriptions
- The absence of reported interactions with other ongoing treatments, particularly benzodiazepines, whose combination with opioids increases the risk of respiratory depression
- The prescriber’s compliance with the new maximum prescription duration rules, which vary by molecule
This regulatory obligation transforms the pharmacist’s role into a true safety filter for medications with a high potential for abuse. The additional workload is real, but most pharmacy software has integrated automatic alerts since spring 2026.
Stock shortages of generic medications: the situation on the ground since winter 2025
Amoxicillin remains the most telling case. Since winter 2025, the availability of essential generics has continued to decline, a finding shared during the 42nd Congress of the USPO in April 2026. Community pharmacists deal daily with these shortages using workaround solutions that satisfy no one.
When a generic is unavailable, the prescriber is contacted to propose a therapeutic alternative. This process takes time, creates frustration for the patient, and slows down the queue. Stock shortages are not an abstract health policy issue in France; it is a problem that is resolved call by call, patient by patient.
Why shortages persist
The production of generics relies on a limited number of manufacturing sites, often located outside Europe. An incident on a single production line can affect the supply of several countries simultaneously. The ANSM regularly publishes lists of medications under tension, but information sometimes arrives after the shortage has already been observed at the counter.
The most organized pharmacists anticipate by monitoring weak signals: lengthening delivery times from wholesalers, partially fulfilled orders. This daily vigilance has now become an integral part of the job.
Paid pharmaceutical consultations: where does France stand compared to the German model
A report from the OECD published in March 2026 points to an acceleration in the adoption of paid pharmaceutical consultations in pharmacies in France. The principle: the pharmacist conducts a structured interview (medication review, support for a chronic patient) and receives dedicated compensation, separate from the margin on products.
The German model, which is older, often serves as a reference. However, the French transposition faces a barrier identified by the same report: the lack of continuing education hinders the expansion of pharmaceutical consultations. Willing pharmacists exist, protocols do as well, but the training time needed to master new areas (smoking cessation, post-stroke follow-up, in-depth vaccination advice) remains difficult to allocate in an understaffed pharmacy.
- Pharmaceutical interviews for patients on anticoagulants or asthmatics have already been in place for several years, with variable adherence rates depending on the regions
- Shared medication reviews for poly-medicated elderly individuals are gaining traction, but their compensation is considered insufficient by part of the profession
- Extension to new chronic conditions (type 2 diabetes, heart failure) is currently under negotiation
This fundamental movement is changing the relationship between the pharmacist and the patient. The pharmacy is becoming a full-fledged consultation space, not just a point of medication dispensing.
The health and pharmacy news of spring 2026 outlines a profession undergoing rapid transformation. Between the digital traceability of opioids, the gradual integration of AI at the counter, and persistent stock shortages, the neighborhood pharmacist is managing increasing complexity with resources that are not growing at the same pace.